Search Results 481-490 of 90945 for Metastasis

  1. Zanzalintinib Versus Everolimus In Participants With Locally Advanced Or Metastatic Neuroendocrine Tumors - Mayo Clinic

    ... metastatic neuroendocrine tumors. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments ...

  2. Stage 4 (metastatic) colon cancer - Doctors and departments - Mayo Clinic

    Mayo Clinic Comprehensive Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center. This designation ...

  3. A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

    About this study. Researchers are looking for new ways to treat metastatic castration-resistant prostate cancer (mCRPC). Researchers have designed a study ...

  4. Clinical trials - Lung Cancer Program

    ... Metastatic Non Small Cell Lung Cancer. Scottsdale/Phoenix, Ariz. This study is a Phase III, randomised, open label, multi-centre study assessing the efficacy ...

  5. Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas - Mayo Clinic

    Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas ... Patients with brain metastasis are ...

  6. Veliparib and Floxuridine in Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, or Fallopian Tube Cancer - Mayo Clinic

    Veliparib and Floxuridine in Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, or Fallopian Tube Cancer · Share · Facebook · Twitter.

  7. Stage 4 (metastatic) colon cancer - Doctors and departments - Mayo Clinic

    ... metastases. Stage 4 (metastatic) colon cancer. Symptoms & causes · Diagnosis & treatment · Doctors & departments · Care at. Mayo Clinic. Research: It's all ...

  8. Phase Ib Study of Axatilimab in Combination with Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer - Mayo Clinic

    Phase Ib Study of Axatilimab in Combination with Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer ... metastatic breast cancer.

  9. Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer - Mayo Clinic

    Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer · Share · Facebook · Twitter.

  10. Maciej M. Mrugala, M.D., Ph.D. - Doctors and Medical Staff - Mayo Clinic

    Primary brain tumors · Metastatic disease including leptomeningeal carcinomatosis, Neurofibromatosis type 1 and 2, Neurologic complications of cancer ...